Advanced Life Sciences, Inc.

- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1998-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
- Conditions
- Melanoma
- Interventions
- Drug: ALS-357
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- Advanced Life Sciences, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT00701987
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia
- First Posted Date
- 2006-06-13
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- Advanced Life Sciences, Inc.
- Target Recruit Count
- 522
- Registration Number
- NCT00336544
- Locations
- 🇺🇸
ARGENTINA - Advanced Life Sciences, Woodridge, Illinois, United States
🇺🇸BULGARIA - Advanced Life Sciences, Woodridge, Illinois, United States
🇺🇸CHILE - Advanced Life Sciences, Woodridge, Illinois, United States
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)
- First Posted Date
- 2006-06-13
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- Advanced Life Sciences, Inc.
- Target Recruit Count
- 584
- Registration Number
- NCT00336505
- Locations
- 🇺🇸
CANADA - Advanced Life Sciences, Woodridge, Illinois, United States
🇺🇸SOUTH AFRICA - Advanced Life Sciences, Woodridge, Illinois, United States
🇺🇸USA - Advanced Life Sciences, Woodridge, Illinois, United States